244 related articles for article (PubMed ID: 21452295)
1. Favorable effect of very early disease-modifying antirheumatic drug treatment on radiographic progression in early inflammatory arthritis: Data from the Étude et Suivi des polyarthrites indifférenciées récentes (study and followup of early undifferentiated polyarthritis).
Lukas C; Combe B; Ravaud P; Sibilia J; Landew R; van der Heijde D
Arthritis Rheum; 2011 Jul; 63(7):1804-11. PubMed ID: 21452295
[TBL] [Abstract][Full Text] [Related]
2. Moderate alcohol consumption is associated with increased radiological progression in women, but not in men, with early rheumatoid arthritis: results from the ESPOIR cohort (Étude et Suivi des Polyarthrites Indifférenciées Récentes).
Sageloli F; Quesada JL; Fautrel B; Salliot C; Gaudin P; Baillet A
Scand J Rheumatol; 2018 Nov; 47(6):440-446. PubMed ID: 29774784
[TBL] [Abstract][Full Text] [Related]
3. The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study.
Kyburz D; Gabay C; Michel BA; Finckh A;
Rheumatology (Oxford); 2011 Jun; 50(6):1106-10. PubMed ID: 21258051
[TBL] [Abstract][Full Text] [Related]
4. Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: results from a large observational inception study.
Bukhari MA; Wiles NJ; Lunt M; Harrison BJ; Scott DG; Symmons DP; Silman AJ
Arthritis Rheum; 2003 Jan; 48(1):46-53. PubMed ID: 12528102
[TBL] [Abstract][Full Text] [Related]
5. Effect of cumulative exposure to corticosteroid and DMARD on radiographic progression in rheumatoid arthritis: results from the ESPOIR cohort.
Louveau B; De Rycke Y; Lafourcade A; Saraux A; Guillemin F; Tubach F; Fautrel B; Hajage D
Rheumatology (Oxford); 2018 Sep; 57(9):1563-1573. PubMed ID: 29796624
[TBL] [Abstract][Full Text] [Related]
6. Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort.
Combe B; Rincheval N; Benessiano J; Berenbaum F; Cantagrel A; Daurès JP; Dougados M; Fardellone P; Fautrel B; Flipo RM; Goupille P; Guillemin F; Le Loët X; Logeart I; Mariette X; Meyer O; Ravaud P; Saraux A; Schaeverbeke T; Sibilia J
J Rheumatol; 2013 Oct; 40(10):1650-7. PubMed ID: 23950185
[TBL] [Abstract][Full Text] [Related]
7. Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study.
Korpela M; Laasonen L; Hannonen P; Kautiainen H; Leirisalo-Repo M; Hakala M; Paimela L; Blåfield H; Puolakka K; Möttönen T;
Arthritis Rheum; 2004 Jul; 50(7):2072-81. PubMed ID: 15248204
[TBL] [Abstract][Full Text] [Related]
8. Patient retention and hand-wrist radiograph progression of rheumatoid arthritis during a 3-year prospective study that prohibited disease modifying antirheumatic drugs.
Paulus HE; Di Primeo D; Sharp JT; Genant HK; Weissman BN; Weisman MH; Sanda M;
J Rheumatol; 2004 Mar; 31(3):470-81. PubMed ID: 14994390
[TBL] [Abstract][Full Text] [Related]
9. Radiological progression in early rheumatoid arthritis after DMARDS: a one-year follow-up study in a clinical setting.
Sanmarti R; Gomez A; Ercilla G; Gratacos J; Larrosa M; Suris X; Vinas O; Salvador G; Munoz-Gomez J; Canete JD
Rheumatology (Oxford); 2003 Sep; 42(9):1044-9. PubMed ID: 12730518
[TBL] [Abstract][Full Text] [Related]
10. Predictors of radiographic progression in the ESPOIR cohort: the season of first symptoms may influence the short-term outcome in early arthritis.
Mouterde G; Lukas C; Logeart I; Flipo RM; Rincheval N; Daurès JP; Combe B
Ann Rheum Dis; 2011 Jul; 70(7):1251-6. PubMed ID: 21515603
[TBL] [Abstract][Full Text] [Related]
11. Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden early arthritis clinic and ESPOIR cohorts.
van Nies JA; Tsonaka R; Gaujoux-Viala C; Fautrel B; van der Helm-van Mil AH
Ann Rheum Dis; 2015 May; 74(5):806-12. PubMed ID: 25561360
[TBL] [Abstract][Full Text] [Related]
12. Referring early arthritis patients within 6 weeks versus 12 weeks after symptom onset: an observational cohort study.
Niemantsverdriet E; Dougados M; Combe B; van der Helm-van Mil AHM
Lancet Rheumatol; 2020 Jun; 2(6):e332-e338. PubMed ID: 38273596
[TBL] [Abstract][Full Text] [Related]
13. Impact of tumour necrosis factor inhibitor treatment on radiographic progression in rheumatoid arthritis patients in clinical practice: results from the nationwide Danish DANBIO registry.
Ornbjerg LM; Ostergaard M; Bøyesen P; Krogh NS; Thormann A; Tarp U; Poulsen UE; Espesen J; Ringsdal VS; Graudal N; Kollerup G; Jensen DV; Madsen OR; Glintborg B; Christensen T; Lindegaard H; Dencker D; Hansen A; Andersen AR; Hetland ML
Ann Rheum Dis; 2013 Jan; 72(1):57-63. PubMed ID: 22532636
[TBL] [Abstract][Full Text] [Related]
14. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
Ciubotariu E; Gabay C; Finckh A;
J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
[TBL] [Abstract][Full Text] [Related]
15. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis.
Finckh A; Liang MH; van Herckenrode CM; de Pablo P
Arthritis Rheum; 2006 Dec; 55(6):864-72. PubMed ID: 17139662
[TBL] [Abstract][Full Text] [Related]
16. Clinical, functional, and radiographic implications of time to treatment response in patients with early rheumatoid arthritis: a posthoc analysis of the PREMIER study.
Keystone EC; Haraoui B; Guérette B; Mozaffarian N; Liu S; Kavanaugh A
J Rheumatol; 2014 Feb; 41(2):235-43. PubMed ID: 24293583
[TBL] [Abstract][Full Text] [Related]
17. Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registry.
Ørnbjerg LM; Østergaard M; Bøyesen P; Krogh NS; Thormann A; Tarp U; Poulsen UE; Espesen J; Schlemmer A; Graudal N; Kollerup G; Jensen DV; Madsen OR; Glintborg B; Christensen T; Lindegaard H; Bøhme W; Hansen A; Andersen AR; Hetland ML
J Rheumatol; 2014 Dec; 41(12):2352-60. PubMed ID: 25274894
[TBL] [Abstract][Full Text] [Related]
18. Equivalent responses to disease-modifying antirheumatic drugs initiated at any time during the first 15 months after symptom onset in patients with seropositive rheumatoid arthritis.
Weng HH; Ranganath VK; Khanna D; Oh M; Furst DE; Park GS; Elashoff DA; Sharp JT; Gold RH; Peter JB; Paulus HE;
J Rheumatol; 2010 Mar; 37(3):550-7. PubMed ID: 20110517
[TBL] [Abstract][Full Text] [Related]
19. Classifying structural joint damage in rheumatoid arthritis as progressive or nonprogressive using a composite definition of joint radiographic change: a preliminary proposal.
Paulus HE; Oh M; Sharp JT; Gold RH; Wong WK; Park GS; Bulpitt KJ;
Arthritis Rheum; 2004 Apr; 50(4):1083-96. PubMed ID: 15077290
[TBL] [Abstract][Full Text] [Related]
20. Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial.
Wassenberg S; Rau R; Steinfeld P; Zeidler H
Arthritis Rheum; 2005 Nov; 52(11):3371-80. PubMed ID: 16255011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
